Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation

Author: Safarinejad, Mohammad Reza

Source: BJU International, Volume 105, Number 1, January 2010 , pp. 73-78(6)

Publisher: Blackwell Publishing

Photosensitivity associated with selective serotonin reuptake inhibitors

Authors: Doffoel-Hantz, V.; Boulitrop-Morvan, C.; Sparsa, A.; Bonnetblanc, J. M.; Dalac, S.; Bédane, C.

Source: Clinical & Experimental Dermatology, Volume 34, Number 8, December 2009 , pp. e763-e765(1)

Publisher: Blackwell Publishing

Atypical Depression: A Comprehensive Review

Authors: Pae, Chi-Un; Tharwani, Haresh; Marks, David M.; Masand, Prakash S.; Patkar, Ashwin A.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1023-1037(15)

Publisher: Adis International

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Preliminary, Single-Blind, Prospective Study

Authors: Pallanti, Stefano; Bernardi, Silvia; Antonini, Sarah; Singh, Nikhilesh; Hollander, Eric

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1047-1055(9)

Publisher: Adis International

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

Authors: Marks, David M.; Shah, Manan J.; Patkar, Ashwin A.; Masand, Prakash S.; Park, Geun-Young; Pae, Chi-Un

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 331-336(6)

Publisher: Bentham Science Publishers

Medication information for Flemish inpatients with major depression: evaluation and construct validity of the Consumer Information Rating Form

Authors: Desplenter, F.; Laekeman, G.; Demyttenaere, K.; Simoens, S.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 6, December 2009 , pp. 645-655(11)

Publisher: Blackwell Publishing

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Author: Hashimoto, Kenji

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 470-474(5)

Publisher: Bentham Science Publishers

Sudden death in patients receiving drugs tending to prolong the QT interval

Authors: Jolly, Kate; Gammage, Michael D.; Cheng, Kar Keung; Bradburn, Peter; Banting, Miriam V.; Langman, Michael J. S.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 743-751(9)

Publisher: Blackwell Publishing

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 12, 1 December 2009 , pp. 761-804(44)

Publisher: Adis International

The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder: A Systematic Review and Meta-Analysis

Authors: Gartlehner, Gerald; Thaler, Kylie; Hansen, Richard A.; Gaynes, Bradley N.

Source: Drug Safety, Volume 32, Number 12, 1 December 2009 , pp. 1159-1173(15)

Publisher: Adis International

Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats

Authors: Chudasama, H.P.; Bhatt, P.A.

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 11, 1 November 2009 , pp. 900-907(8)

Publisher: NRC Research Press

The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies

Authors: Carrillo, Maria; Ricci, Lesley; Coppersmith, Glen; Melloni, Richard

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 349-368(20)

Publisher: Springer

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response

Authors: Min, Wenjiao; Li, Tao; Ma, Xiaohong; Li, Zhengyu; Yu, Tao; Gao, Dong; Zhang, Bo; Yun, Yang; Sun, Xueli

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 409-417(9)

Publisher: Springer

Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds

Authors: Bergen, Helen; Hawton, Keith; Murphy, Elizabeth; Cooper, Jayne; Kapur, Navneet; Stalker, Carol; Waters, Keith

Source: British Journal of Clinical Pharmacology, Volume 68, Number 4, October 2009 , pp. 618-629(12)

Publisher: Blackwell Publishing

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications

Authors: Abdel-Hamid, Ibrahim A; Andersson, Karl-Erik

Source: Pharmacogenomics, Volume 10, Number 10, October 2009 , pp. 1625-1644(20)

Publisher: Future Medicine

A biobehavioural model of the night eating syndrome

Authors: Stunkard, A. J.; Allison, K. C.; Lundgren, J. D.; O'Reardon, J. P.

Source: Obesity Reviews, Volume 10, Supplement 2, November 2009 , pp. 69-77(9)

Publisher: Blackwell Publishing

Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications

Authors: Dremencov, Eliyahu; Mansari, Mostafa e.; Blier, Pierre

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1061-1068(8)

Publisher: Bentham Science Publishers

Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors

Authors: Guiard, Bruno P.; Mansari, Mostafa E.; Blier, Pierre

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1069-1084(16)

Publisher: Bentham Science Publishers

The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression (Supplementary Tables)

Authors: Ruf, B. M.; Bhagwagar, Z.

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1118-1138(21)

Publisher: Bentham Science Publishers